biotech / news / / The Economic Times
Emcure Pharmaceuticals is boosting domestic expansion, R&D, and manufacturing.
Emcure Pharmaceuticals is actively seeking both domestic and international acquisitions for expansion.
KEY POINTS
- The Novo Nordisk partnership allows Emcure to distribute semaglutide under the Poviztra brand.
- New product launches are projected to contribute early-to-mid-teens percentage to growth in five years.
- Emcure is strategically focusing on complex injectables and biosimilars, citing significant untapped potential.
COMPANIES
Summarized by Newsio from The Economic Times. How we summarize →